Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers

Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers

US Patent 11325967 · Granted May 10, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-ACTH antibodies and use thereof2025
Humanized anti-ACTH antibodies and use thereof2025
Humanized anti-ACTH antibodies and use thereof2025
Bispecific tetravalent antibodies and methods of making and using thereof2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025
Treatment of headache using anti-CGRP antibodies2025
Treatment of most bothersome symptom (MBS) associated with migraine using anti-C2025
Guidance and navigation control proteins and method of making and using thereof2025
Anti-ACTH antibodies and use thereof2025
Anti-ACTH antibodies and use thereof2025
Anti-ACTH antibodies and use thereof2025
Acute treatment and rapid treatment of headache using anti-CGRP antibodies2025